MED13

mediator complex subunit 13, the group of Mediator complex

Basic information

Region (hg38): 17:61942605-62065278

Previous symbols: [ "THRAP1" ]

Links

ENSG00000108510NCBI:9969OMIM:603808HGNC:22474Uniprot:Q9UHV7AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • intellectual developmental disorder 61 (Definitive), mode of inheritance: AD
  • syndromic intellectual disability (Supportive), mode of inheritance: AD
  • intellectual developmental disorder 61 (Strong), mode of inheritance: AD
  • intellectual developmental disorder 61 (Strong), mode of inheritance: AD
  • complex neurodevelopmental disorder (Definitive), mode of inheritance: AD
  • intellectual developmental disorder 61 (Strong), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Intellectual developmental disorder, autosomal dominant 61ADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Musculoskeletal; Neurologic; Ophthalmologic29740699

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MED13 gene.

  • not_provided (256 variants)
  • Inborn_genetic_diseases (220 variants)
  • Intellectual_developmental_disorder_61 (100 variants)
  • MED13-related_disorder (59 variants)
  • not_specified (10 variants)
  • See_cases (4 variants)
  • Autosomal_dominant_isolated_somatotropin_deficiency (3 variants)
  • Neurodevelopmental_disorder (2 variants)
  • Autism_spectrum_disorder (2 variants)
  • Intellectual_disability (2 variants)
  • MED13-related_neurodevelopmental_disorder (1 variants)
  • CDK8-kinase_module-associated_disorder (1 variants)
  • Intellectual_disability,_autosomal_dominant_13 (1 variants)
  • MED13-associated_disorder (1 variants)
  • Developmental_disorder (1 variants)
  • Autistic_behavior (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MED13 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000005121.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
33
clinvar
7
clinvar
43
missense
2
clinvar
12
clinvar
364
clinvar
83
clinvar
6
clinvar
467
nonsense
12
clinvar
5
clinvar
2
clinvar
19
start loss
0
frameshift
12
clinvar
10
clinvar
1
clinvar
23
splice donor/acceptor (+/-2bp)
9
clinvar
2
clinvar
11
Total 35 29 370 116 13

Highest pathogenic variant AF is 0.00000137905

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MED13protein_codingprotein_codingENST00000397786 30122678
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.001.84e-16124782031247850.0000120
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.628711.12e+30.7790.000055614195
Missense in Polyphen314529.750.592736708
Synonymous-1.384223881.090.00001914248
Loss of Function9.19098.40.000.000004921257

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.00009280.0000928
European (Non-Finnish)0.000008860.00000883
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. {ECO:0000269|PubMed:16595664}.;
Pathway
Thyroid hormone signaling pathway - Homo sapiens (human);Developmental Biology;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Transcriptional regulation of white adipocyte differentiation (Consensus)

Recessive Scores

pRec
0.134

Intolerance Scores

loftool
0.0136
rvis_EVS
-1.43
rvis_percentile_EVS
4.05

Haploinsufficiency Scores

pHI
0.546
hipred
Y
hipred_score
0.777
ghis
0.602

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.692

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Med13
Phenotype
liver/biliary system phenotype; homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype;

Zebrafish Information Network

Gene name
med13b
Affected structure
cranial neural crest cell
Phenotype tag
abnormal
Phenotype quality
mislocalised

Gene ontology

Biological process
regulation of transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;intracellular steroid hormone receptor signaling pathway;androgen receptor signaling pathway;cholesterol homeostasis;negative regulation of DNA-binding transcription factor activity;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;triglyceride homeostasis
Cellular component
nucleus;nucleoplasm;membrane;mediator complex
Molecular function
transcription coregulator activity;transcription coactivator activity;nuclear receptor transcription coactivator activity;signaling receptor activity;vitamin D receptor binding;thyroid hormone receptor binding